Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
Clinical trial NCT07269249 · RECRUITING
Trial details
- NCT number
- NCT07269249
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.